Intravenous Fluid Therapy (Crystalloids)
Treatment for Dengue
Typical Dosage: Initial 10-20 mL/kg bolus over 15-30 min, then maintenance 3-5 mL/kg/hr, guided by hemodynamics
Effectiveness
95%
Safety Score
65%
Clinical Trials
50
Participants
20K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
Dosage Range
Initial 10-20 mL/kg bolus over 15-30 min, then maintenance 3-5 mL/kg/hr, guided by hemodynamics
Time to Effect
Immediate
Treatment Duration
12-72 hours
Evidence Quality
HIGHNumber Needed to Treat (NNT)
5(Treat 5 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
20(Treat 20 patients to see 1 additional serious adverse event)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$150
Monitoring:$8,000
Side Effect Mgmt:$500
Total Annual:$8,650
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTQALYs Gained
0.8
Outcome-Based Costs
Cost per Responder
$9,611.11
Intravenous Fluid Therapy (Crystalloids) Outcomes
for Dengue
Efficacy Outcomes
Overall Effectiveness
+95%
Response Rate
+90%
Common Side Effects
Fluid overload (pulmonary edema)
+8%
Electrolyte imbalance
+5%
Catheter-related infection
+1%
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov